Frontiers in Molecular Neuroscience (Mar 2024)

Human mutations in SLITRK3 implicated in GABAergic synapse development in mice

  • Stephanie Efthymiou,
  • Stephanie Efthymiou,
  • Wenyan Han,
  • Muhammad Ilyas,
  • Jun Li,
  • Yichao Yu,
  • Marcello Scala,
  • Marcello Scala,
  • Marcello Scala,
  • Nancy T. Malintan,
  • Muhammad Ilyas,
  • Nikoleta Vavouraki,
  • Nikoleta Vavouraki,
  • Kshitij Mankad,
  • Kshitij Mankad,
  • Reza Maroofian,
  • Clarissa Rocca,
  • Vincenzo Salpietro,
  • Shenela Lakhani,
  • Eric J. Mallack,
  • Timothy Blake Palculict,
  • Hong Li,
  • Guojun Zhang,
  • Guojun Zhang,
  • Faisal Zafar,
  • Nuzhat Rana,
  • Noriko Takashima,
  • Hayato Matsunaga,
  • Claudia Manzoni,
  • Pasquale Striano,
  • Pasquale Striano,
  • Mark F. Lythgoe,
  • Jun Aruga,
  • Jun Aruga,
  • Wei Lu,
  • Henry Houlden

DOI
https://doi.org/10.3389/fnmol.2024.1222935
Journal volume & issue
Vol. 17

Abstract

Read online

This study reports on biallelic homozygous and monoallelic de novo variants in SLITRK3 in three unrelated families presenting with epileptic encephalopathy associated with a broad neurological involvement characterized by microcephaly, intellectual disability, seizures, and global developmental delay. SLITRK3 encodes for a transmembrane protein that is involved in controlling neurite outgrowth and inhibitory synapse development and that has an important role in brain function and neurological diseases. Using primary cultures of hippocampal neurons carrying patients’ SLITRK3 variants and in combination with electrophysiology, we demonstrate that recessive variants are loss-of-function alleles. Immunostaining experiments in HEK-293 cells showed that human variants C566R and E606X change SLITRK3 protein expression patterns on the cell surface, resulting in highly accumulating defective proteins in the Golgi apparatus. By analyzing the development and phenotype of SLITRK3 KO (SLITRK3–/–) mice, the study shows evidence of enhanced susceptibility to pentylenetetrazole-induced seizure with the appearance of spontaneous epileptiform EEG as well as developmental deficits such as higher motor activities and reduced parvalbumin interneurons. Taken together, the results exhibit impaired development of the peripheral and central nervous system and support a conserved role of this transmembrane protein in neurological function. The study delineates an emerging spectrum of human core synaptopathies caused by variants in genes that encode SLITRK proteins and essential regulatory components of the synaptic machinery. The hallmark of these disorders is impaired postsynaptic neurotransmission at nerve terminals; an impaired neurotransmission resulting in a wide array of (often overlapping) clinical features, including neurodevelopmental impairment, weakness, seizures, and abnormal movements. The genetic synaptopathy caused by SLITRK3 mutations highlights the key roles of this gene in human brain development and function.

Keywords